Status:
COMPLETED
Rapid Benzodiazepine Detoxification Using Flumazenil - 1
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance-Related Disorders
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
January 1 1993
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 1994
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00000246
Start Date
January 1 1993
End Date
December 1 1994
Last Update
September 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University, Psychiatry
New Haven, Connecticut, United States, 06519